Maus A, Thompson C, Grebe S
J Endocr Soc. 2025; 9(3):bvaf015.
PMID: 39911521
PMC: 11791033.
DOI: 10.1210/jendso/bvaf015.
Giovanella L, DAurizio F, Petranovic Ovcaricek P, Gorges R
J Clin Med. 2024; 13(9).
PMID: 38730992
PMC: 11084486.
DOI: 10.3390/jcm13092463.
Wenk D, Zuo C, Kislinger T, Sepiashvili L
Clin Proteomics. 2024; 21(1):6.
PMID: 38287260
PMC: 10826105.
DOI: 10.1186/s12014-024-09452-1.
Huynh H, Kuch K, Orquillas A, Forrest K, Barahona-Carrillo L, Keene D
Clin Chem. 2023; 69(7):734-745.
PMID: 37279935
PMC: 10320014.
DOI: 10.1093/clinchem/hvad056.
Lin Y, Thomas S
J Mass Spectrom Adv Clin Lab. 2023; 28:30-34.
PMID: 36865788
PMC: 9971545.
DOI: 10.1016/j.jmsacl.2023.02.001.
Liquid chromatography-tandem mass spectrometry for clinical diagnostics.
Thomas S, French D, Jannetto P, Rappold B, Clarke W
Nat Rev Methods Primers. 2022; 2(1):96.
PMID: 36532107
PMC: 9735147.
DOI: 10.1038/s43586-022-00175-x.
A distributable LC-MS/MS method for the measurement of serum thyroglobulin.
Shi J, Phipps W, Owusu B, Henderson C, Laha T, Becker J
J Mass Spectrom Adv Clin Lab. 2022; 26:28-33.
PMID: 36388059
PMC: 9641599.
DOI: 10.1016/j.jmsacl.2022.09.005.
Quantitation of Thyroglobulin in Serum Using SISCAPA and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
van der Gugten J, Razavi M, Holmes D
Methods Mol Biol. 2022; 2546:473-483.
PMID: 36127614
DOI: 10.1007/978-1-0716-2565-1_42.
Rational Design and Development of SARS-CoV-2 Serological Diagnostics by Immunoprecipitation-Targeted Proteomics.
Fu Z, Rais Y, Dara D, Jackson D, Drabovich A
Anal Chem. 2022; 94(38):12990-12999.
PMID: 36095284
PMC: 9523617.
DOI: 10.1021/acs.analchem.2c01325.
Review of the Use of Liquid Chromatography-Tandem Mass Spectrometry in Clinical Laboratories: Part II-Operations.
Rappold B
Ann Lab Med. 2022; 42(5):531-557.
PMID: 35470272
PMC: 9057814.
DOI: 10.3343/alm.2022.42.5.531.
Listening to your mass spectrometer: An open-source toolkit to visualize mass spectrometer data.
Pablo A, Hoofnagle A, Mathias P
J Mass Spectrom Adv Clin Lab. 2022; 23:44-49.
PMID: 35028636
PMC: 8739458.
DOI: 10.1016/j.jmsacl.2021.12.003.
Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens.
Whiteaker J, Lundeen R, Zhao L, Schoenherr R, Burian A, Huang D
Front Immunol. 2021; 12:765898.
PMID: 34858420
PMC: 8632241.
DOI: 10.3389/fimmu.2021.765898.
Development and Validation of a Novel LC-MS/MS Assay for C-Peptide in Human Serum.
Owusu B, Pflaum H, Garner R, Foulon N, Laha T, Hoofnagle A
J Mass Spectrom Adv Clin Lab. 2021; 19:1-6.
PMID: 34723236
PMC: 8553002.
DOI: 10.1016/j.jmsacl.2020.12.001.
Targeted Mass Spectrometry Enables Quantification of Novel Pharmacodynamic Biomarkers of ATM Kinase Inhibition.
Whiteaker J, Wang T, Zhao L, Schoenherr R, Kennedy J, Voytovich U
Cancers (Basel). 2021; 13(15).
PMID: 34359745
PMC: 8345163.
DOI: 10.3390/cancers13153843.
Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.
Kennedy J, Whiteaker J, Kennedy L, Bosch D, Lerch M, Schoenherr R
Clin Chem. 2021; 67(7):1008-1018.
PMID: 34136904
PMC: 8260184.
DOI: 10.1093/clinchem/hvab047.
Quantification of Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Protein Expression in Bone Biopsies by Targeted Mass Spectrometry without Acid Decalcification.
Schoenherr R, Voytovich U, Whiteaker J, Gadi V, Gralow J, Paulovich A
Clin Chem. 2020; 66(11):1459-1461.
PMID: 33106847
PMC: 8536214.
DOI: 10.1093/clinchem/hvaa220.
Multiplexed Proteomic Analysis for Diagnosis and Screening of Five Primary Immunodeficiency Disorders From Dried Blood Spots.
Collins C, Yi F, Dayuha R, Whiteaker J, Ochs H, Freeman A
Front Immunol. 2020; 11:464.
PMID: 32296420
PMC: 7141245.
DOI: 10.3389/fimmu.2020.00464.
Rapid Multiplexed Proteomic Screening for Primary Immunodeficiency Disorders From Dried Blood Spots.
Collins C, Chang I, Jung S, Dayuha R, Whiteaker J, Segundo G
Front Immunol. 2018; 9:2756.
PMID: 30564228
PMC: 6288356.
DOI: 10.3389/fimmu.2018.02756.
Clinical potential of mass spectrometry-based proteogenomics.
Zhang B, Whiteaker J, Hoofnagle A, Baird G, Rodland K, Paulovich A
Nat Rev Clin Oncol. 2018; 16(4):256-268.
PMID: 30487530
PMC: 6448780.
DOI: 10.1038/s41571-018-0135-7.
Calibration Using a Single-Point External Reference Material Harmonizes Quantitative Mass Spectrometry Proteomics Data between Platforms and Laboratories.
Pino L, Searle B, Huang E, Noble W, Hoofnagle A, MacCoss M
Anal Chem. 2018; 90(21):13112-13117.
PMID: 30350613
PMC: 6854904.
DOI: 10.1021/acs.analchem.8b04581.
